SoMS Honours
Potential Projects » Cell Biology & Stem Cells
| Understanding how stem cells maintain the cornea under steady-state | |
| Understanding how stem cells partake in wound-healing | |
| Discovering better markers of corneal stem cells in order to devise better transplantation/grafting strategies for patients with severe corneal disease | |
| Understanding how the cornea is impacted by metabolic disease | |
|
Prince of Wales Clinical School |
(Epi-)Genetic profiling of circulating cancer (stem) cells in patients with metastatic pancreatic ductal adenocarcinoma |
|
Garvan Institute of Medical Research |
Using the immune system to regenerate damaged organs |
|
Dr Siiri Iismaa, Prof Robert M Graham & Dr Amy Nicks Victor Chang Cardiac Research Institute |
Understanding the regulation of gene expression in cardiac development and regeneration |
|
Dr Siiri Iismaa, Prof Robert M Graham & Dr Monique Bax Victor Chang Cardiac Research Institute |
Elucidating the genetics and biology of spontaneous coronary artery dissection (SCAD): a life-threatening heart disease of women |
|
Prince of Wales Clinical School |
Evaluation of cell membrane and extracellular matrix of brain tumours to aid targeting (Collaboration with Lowy cancer institute and Faculty of Engineering UNSW) |
|
SWS Clinical School and Ingham Institute for Applied Medical Research |
Circulating tumour cells in liver cancer: Personalised cancer diagnosis and management (Honours & MSc) |
|
Graduate School of Biomedical Engineering |
Human periosteum derived mesenchymal stem cells (pdMSCs) |
|
Dr Julie Thoms & Prof John Pimanda Adult Cancer Program |
The role of stem cell enhancers in normal and leukaemic blood development |
| Promoting NAD biosynthesis to prevent diabetes and cancer | |
| Understanding the role of mitochondria as signaling organelles | |
|
Prof Jamie Vandenberg & Dr Carus Lau Victor Chang Cardiac Research Institute |
Structural Basis of drug binding to hERG K+ channel |
|
Children's Cancer Institute |
Epigenetic regulation of leukaemia stem cells |
|
Children's Cancer Institute |
Developing a new curative therapy for aggressive leukaemia |
|
Dr Shafagh Waters & Prof Adam Jaffe Australasian Centre for Personalized Cystic Fibrosis Medicine (ACPCFM) |
Cystic fibrosis derived mini-organs; a model system for precision medicine |
|
Dr Shafagh Waters & Prof Adam Jaffe Australasian Centre for Personalized Cystic Fibrosis Medicine (ACPCFM) |
Targeted activation of CFTR via manipulation of a non-coding RNA pathway |
|
Dr Shafagh Waters & Prof Adam Jaffe Australasian Centre for Personalized Cystic Fibrosis Medicine (ACPCFM) |
Harnessing protective and antiapoptotic function of stress granules (SGs) in CF |
|
Dr Shafagh Waters & Prof Adam Jaffe Australasian Centre for Personalized Cystic Fibrosis Medicine (ACPCFM) |
Serum biomarkers of Cystic Fibrosis Related Diabetes (CFRD) |
|
Prof John Whitelock & A/Prof Megan Lord Graduate School of Biomedical Engineering |
Re-engineering the basement membrane with CRISPR/Cas to investigate how tumour cells interact with its components to facilitate invasion and metastasis |
|
Cellular senescence in ageing, diabetes and cancer |